SCHEMBL13809244

SCHEMBL13809244

COc1ccc(OC)c2c1CCN(C(=O)/C=C\C(=O)O)C2c1cccc(Cl)c1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2C Q14957 1/20 0.36
ALDH1A1 P00352 2/20 0.36
HTT P42858 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
NPC1 O15118 1/20 0.36
MITF O75030 1/20 0.36
LMNA P02545 1/20 0.36
XBP1 P17861 1/20 0.36
RAB9A P51151 1/20 0.36
CMA1 P23946 1/20 0.35
TRPV1 Q8NER1 1/20 0.34
KLKB1 P03952 3/20 0.34
RORC P51449 2/20 0.34
F11 P03951 2/20 0.34
NOTUM Q6P988 1/20 0.34
NFE2L2 Q16236 1/20 0.34
PTGDR2 Q9Y5Y4 1/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13809007 0.82 GRIN2C (0.43) GRIN2CALDH1A1HTTNPSR1NPC1
SCHEMBL13809253 0.80 GRIN2C (0.43) GRIN2CALDH1A1POLBMEN1KMT2A
SCHEMBL13809228 0.79 GRIN2C (0.43) GRIN2CMEN1KMT2A
SCHEMBL13809241 0.79 GRIN2C (0.41) GRIN2CALDH1A1HTTNPSR1NPC1
SCHEMBL13809234 0.77 GRIN2C (0.40) GRIN2CMEN1KMT2A
SCHEMBL13809226 0.72 ABCG2 (0.39) GRIN2CMAPTMEN1KMT2A
SCHEMBL13808738 0.68 MAPT (0.42) MAPT
Fumaric Acid SCHEMBL10516264 0.65 OPRD1 (0.71) NPSR1LMNAMEN1KMT2A
SCHEMBL13809242 0.64 KIF11 (0.45) GRIN2CALDH1A1LMNAKMT2A
SCHEMBL2791655 0.64 ESR1 (0.50) ALDH1A1HTTNPSR1NPC1MITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009073545-A2 TETRAHYDRO-ISOQUINOLINE PPAT INHIBITORS AS ANTIBACTERIAL AGENTS MAXTHERA, INC. (US) 2009-06-11 WO disclosed